Results

Genmab A/S

10/15/2021 | Press release | Distributed by Public on 10/15/2021 11:05

Genmab Announces that Janssen has Received Positive CHMP Opinion for RYBREVANT® (amivantamab) for Patients with Advanced Non-small Cell Lung Cancer with EGFR Exon 20 Insertion[...]